The global organs-on-chips market size is expected to reach USD 209.4 Million at a steady CAGR of 28.1% in 2028, according to latest analysis by Émergen Research Organs-on-chips market in North America accounted for largest revenue share in 2020, attributed to increasing research and development activities of organs-on-chips, rapid adoption of advanced technologies, and increased investments by pharmaceutical companies in drug discovery. In addition, presence of leading firms providing organs-on-chips are causative of robust market growth in the region. Key players in the market include MIMETAS BV, SynVivo Inc., Emulate Inc., InSphero AG, CN Bio, Nortis Inc., Organovo Holdings Inc., TissUse GmbH, AxoSim Inc., and ĶǏrkstall Ltd.